Oxaprozin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Oxaprozin.
| Product ID | 71335-0393_c9f27654-c926-4a7e-b4fa-685ed58ea778 |
| NDC | 71335-0393 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oxaprozin |
| Generic Name | Oxaprozin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2001-01-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075855 |
| Labeler Name | Bryant Ranch Prepack |
| Substance Name | OXAPROZIN |
| Active Ingredient Strength | 600 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2007-09-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA075855 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-09-12 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA075855 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-09-12 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA075855 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-09-12 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA075855 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-09-12 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA075855 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-09-12 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA075855 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-09-12 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA075855 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-09-12 |
| Marketing End Date | 2019-09-30 |
| Ingredient | Strength |
|---|---|
| OXAPROZIN | 600 mg/1 |
| SPL SET ID: | dcb85e40-3427-4e56-910d-c1b07bb5c0fa |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-0924 | Oxaprozin | Oxaprozin |
| 0185-0141 | Oxaprozin | Oxaprozin |
| 21695-100 | Oxaprozin | Oxaprozin |
| 50090-2012 | Oxaprozin | Oxaprozin |
| 50436-2899 | Oxaprozin | Oxaprozin |
| 52959-800 | Oxaprozin | Oxaprozin |
| 55111-170 | Oxaprozin | Oxaprozin |
| 55289-601 | Oxaprozin | Oxaprozin |
| 57664-391 | Oxaprozin | Oxaprozin |
| 59762-6002 | oxaprozin | oxaprozin |
| 60760-092 | Oxaprozin | Oxaprozin |
| 60760-203 | Oxaprozin | Oxaprozin |
| 60760-382 | Oxaprozin | Oxaprozin |
| 61919-178 | OXAPROZIN | OXAPROZIN |
| 61919-673 | OXAPROZIN | OXAPROZIN |
| 62135-176 | OXAPROZIN | OXAPROZIN |
| 68151-0523 | Oxaprozin | Oxaprozin |
| 69238-1120 | Oxaprozin | Oxaprozin |
| 70332-311 | Oxaprozin | Oxaprozin |
| 70332-310 | OXAPROZIN | OXAPROZIN |
| 71335-0617 | Oxaprozin | Oxaprozin |
| 71335-0393 | Oxaprozin | Oxaprozin |
| 71335-0902 | Oxaprozin | Oxaprozin |
| 63629-1345 | Oxaprozin | Oxaprozin |
| 66336-722 | Oxaprozin | Oxaprozin |
| 72189-077 | OXAPROZIN | OXAPROZIN |
| 0025-1381 | Daypro | oxaprozin |
| 55289-453 | Daypro | oxaprozin |